Skip to main content
. 2016 Apr 13;11(4):e0153567. doi: 10.1371/journal.pone.0153567

Fig 8. Frequency of LDGs in the PBMCs of PTB patient correlated with disease severity.

Fig 8

(A) PBMCs from PTB patients with mild-to-moderate disease (PTB-mod) and advanced disease (PTB-adv) were isolated by Ficoll gradient centrifugation and the percentages of CD14low CD15+ LDGs were determined by FCM. Each symbol denotes a single subject, and the mean ± SEM for each study population is shown. Statistical significance was determined by a Student t test. (B) PBMCs from healthy control subjects, PTB patients who had not received anti-tuberculous therapy (NATT-PTB), and those who had received 2 weeks of ATT in hospital (ATT-2w -PTB) or 6 months of ATT in the home following 2 weeks of hospitalization (ATT-6m -PTB) were isolated by Ficoll gradient centrifugation and the percentages of CD14low CD15+ LDGs were determined by FCM. Each symbol denotes a single subject, and the mean ± SEM for each study population is shown. Statistical significance was determined by a one-way ANOVA followed by the Gabriel post hoc test. **P < 0.01.